Daxor Announces It Has Submitted Its Blood Volume Analyzer, Daxor BVA, To The FDA
The New BVA System is Designed to be Significantly Faster, Simpler and Give Results at the Bedside
Potential clearance is expected during the first half of 2024. The Company's mission is to advance healthcare by enabling optimal fluid management.